Tag: invokana
Invokana Doubles Diabetic Ketoacidosis Risk, Study Finds
The diabetes drug Invokana has been linked to a doubled increased risk of ketoacidosis (too much acid in the blood) compared to diabetes drugs in the DPP-4 inhibitor class, according to a study published in the New England Journal of...
Invokana Poses 2X Leg, Foot Amputation Risk: FDA Black Box Warning
The diabetes drug canagliflozin, the active ingredient in Invokana, Invokamet, and Invokamet XR, doubles the risk of amputations in diabetic foot disease, according to a new FDA Black Box warning label.
Invokana Lawsuits Centralized in New Jersey MDL
Nearly 100 lawsuits involving kidney failure, ketoacidosis, and other side effects of Janssen Pharmaceuticals' diabetes drugs Invokana and Invokamet have been centralized under one federal judge in New Jersey.
FDA Strengthens Kidney Warnings for Invokana, Other Diabetes Drugs
Diabetes patients on medications like Invokana have a higher risk of developing severe kidney problems, according to a new warning from the FDA.
Invokana Amputation Risk Under Review by FDA
FDA investigates study linking diabetes drugs Invokana and Invokamet with a doubled risk of leg, foot, and toe amputations.